-
Product Insights
Nebulizer Systems Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Nebulizer Systems Pipeline Market Overview Nebulizer is a device which helps in direct delivery of medicine in case of respiratory disorders. The Nebulizer Systems pipeline market research report provides comprehensive information about the pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Territories · United States · Europe · China · Australia · Canada · Israel · New Zealand · United Kingdom Key Regulatory...
-
Product Insights
Quang Ngai Comm – Dung Quat – Sa Huynh Coastal Road Phase IIA – Quang Ngai
Equip yourself with the essential tools needed to make informed and profitable decisions with our Quang Ngai Comm – Dung Quat - Sa Huynh Coastal Road Phase IIA – Quang Ngai report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose...
-
Company Profile
Galmed Pharmaceuticals Ltd – Company Profile
Galmed Pharmaceuticals Ltd (Galmed Pharmaceuticals) is a clinical-stage drug development biopharmaceutical company for liver, metabolic and inflammatory diseases. The company focuses on the development of therapeutics for the treatment of liver diseases. Galmed Pharmaceuticals develops Aramchol, an oral therapy, which is in ARREST study, a Phase IIb clinical study for the treatment of patients with overweight or obesity, and who are pre-diabetic or type-II-diabetic with nonalcoholic steatohepatitis. It also evaluates Aramchol through ARRIVE Study, a proof-of-concept Phase IIa clinical trial,...
Add to Basket -
Product Insights
Transmucosal Drug Delivery Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Transmucosal Drug Delivery Pipeline Market Report Overview A Transmucosal drug delivery device is intended for the localized delivery of medications through a mucous membrane. The transmucosal drug delivery pipeline market research report provides comprehensive information about the transmucosal drug delivery pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segment · Nasal · Vaginal · Buccal Delivery · Rectal Key Territories · The US...
-
Product Insights
Toxicology Tests – Laboratory Corp of America Holdings – PROFILE-IIA
GlobalData, the industry analysis specialist, has released its latest report: Toxicology Tests - Laboratory Corp of America Holdings - PROFILE-IIA. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of medical devices is also impacted...
-
Product Insights
Neurosurgical Products Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Neurosurgical Products Pipeline Market Report Overview The neurosurgical products pipeline market research report provides comprehensive information about the neurosurgical products pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments · Dura Substitutes · Neuroendoscopes · Neurosurgical Drills · Synthetic Dura Substitutes · Neurosurgical Drills · Biological Dura Substitutes Key Territories · The US · Europe · Canada · Israel · Japan · Philippines...
-
Product Insights
Toxicology Tests, LABORATORY CORP OF AMERICA HOLDINGS, PROFILE-IIA, pricing in the Denmark, 2022-2025
GlobalData, the industry analysis specialist, has released its latest report: “Toxicology Tests, LABORATORY CORP OF AMERICA HOLDINGS, PROFILE IIA, pricing in the Denmark, 2022 2025”. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of...
-
Product Insights
Toxicology Tests, LABORATORY CORP OF AMERICA HOLDINGS, PROFILE-IIA, pricing in the Canada, 2022-2025
GlobalData, the industry analysis specialist, has released its latest report: “Toxicology Tests, LABORATORY CORP OF AMERICA HOLDINGS, PROFILE IIA, pricing in the Canada, 2022 2025”. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of...
-
Product Insights
Toxicology Tests, LABORATORY CORP OF AMERICA HOLDINGS, PROFILE-IIA, pricing in the Finland, 2022-2025
GlobalData, the industry analysis specialist, has released its latest report: “Toxicology Tests, LABORATORY CORP OF AMERICA HOLDINGS, PROFILE IIA, pricing in the Finland, 2022 2025”. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of...
-
Product Insights
Toxicology Tests, LABORATORY CORP OF AMERICA HOLDINGS, PROFILE-IIA, pricing in the Australia, 2022-2025
GlobalData, the industry analysis specialist, has released its latest report: “Toxicology Tests, LABORATORY CORP OF AMERICA HOLDINGS, PROFILE IIA, pricing in the Australia, 2022 2025”. The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches. In addition, the final selling pricing of...